Nobel Award Honors Pioneering Immune System Discoveries

The prestigious award in medical science has been awarded for revolutionary findings that illuminate how the body's defense network attacks dangerous infections while sparing the body's own cells.

A trio of renowned researchers—from Japan Shimon Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—received this accolade.

The work identified unique "sentinels" within the immune system that remove rogue defense cells that could harming the body.

These findings are now enabling new therapies for autoimmune diseases and cancer.

The laureates will divide a prize fund worth 11m SEK.

Crucial Discoveries

"The work has been essential for comprehending how the immune system functions and the reason we don't all develop severe self-attack conditions," commented the head of the award panel.

This trio's research explain a core question: In what way does the immune system protect us from countless invaders while keeping our healthy cells intact?

The immune system employs immune cells that scan for indicators of disease, even viruses and bacteria it has never encountered.

These cells utilize detectors—called recognition units—that are produced randomly in countless variations.

This provides the immune system the ability to combat a broad range of threats, but the unpredictability of the process inevitably produces white blood cells that may target the body.

Security Guards of the Body

Researchers previously knew that some of these problematic defense cells were eliminated in the thymus—the site where immune cells develop.

The latest Nobel Prize honors the identification of T-reg cells—described as the body's "security guards"—which travel through the system to disarm other defenders that attack the healthy cells.

We know that this process malfunctions in autoimmune diseases such as juvenile diabetes, MS, and rheumatoid arthritis.

The Nobel panel stated, "These discoveries have laid the foundation for a novel area of research and accelerated the development of innovative treatments, for instance for tumors and autoimmune diseases."

In cancer, regulatory T-cells block the body from fighting the tumor, so research are focused on reducing their quantity.

For autoimmune diseases, experiments are exploring increasing regulatory T-cells so the body is not being harmed. A comparable approach could also be useful in minimizing the chances of organ transplant failure.

Pioneering Experiments

Prof Shimon Sakaguchi, from Osaka University, performed tests on mice that had their thymus removed, causing autoimmune disease.

He demonstrated that introducing defense cells from other animals could prevent the disease—suggesting there was a mechanism for blocking immune cells from harming the host.

Dr. Brunkow, affiliated with the Institute for Systems Biology in a US city, and Fred Ramsdell, currently at a biotech firm in San Francisco, were studying an genetic immune disorder in mice and people that led to the identification of a gene critical for how T-regs function.

"The pioneering work has revealed how the body's defenses is controlled by T-reg cells, stopping it from accidentally attacking the body's own tissues," commented a prominent physiology specialist.

"This research is a striking illustration of how fundamental physiological research can have far-reaching implications for public health."